home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Receptor Signalling In Pairs

  January, 24 2008 9:07
your information resource in human molecular genetics

Scientists have discovered new information about the way that small molecules cause cell signalling, according to a paper to be published online in Nature Chemical Biology. This insight could have major implications in regards to how drugs are developed.

G protein-coupled receptors, or GPCRs, are major drug targets because they bind to molecules that are outside the cell, and this binding causes big changes inside the cell. This means that a potential drug doesn't have to be able to cross the cell membrane to be active, which is simplifies the design of the drug.

Jean-Pierre Vilardaga and colleagues now find that, for some GPCRs that come together in pairs, the signaling by these pairs of receptors is different than signalling by a single receptor. This result will have particular relevance for scientists developing combination drugs, as the mixing of two individual small molecules may not cause the expected biological effect.

Author contact:

Jean-Pierre Vilardaga (Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA)
E-mail: vilardaga.jeanpierre@mgh.harvard.edu

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.